New pill aims to tame iron overload in genetic disorder

This early-stage trial tests an oral drug called BBI-001 for hereditary hemochromatosis, a condition where the body stores too much iron. The study has two parts: one checks safety in healthy volunteers, and the other measures how well the drug controls iron levels in patients. About 34 people will take part, with some receiving the drug and others a placebo.